Vor Biopharma Inc is a clinical stage cell therapy company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VOR is expected to report earnings to fall 10.40% to -22 cents per share on August 07
Q2'25
Est.
$-0.22
Q1'25
Est.
$-0.25
Q4'24
Missed
by $0.10
Q3'24
Est.
$-0.40
Q2'24
Beat
by $0.01
The last earnings report on May 08 showed earnings per share of -25 cents, beating the estimate of -25 cents. With 1.22M shares outstanding, the current market capitalization sits at 26.74M.